Increase in α-defensins during rhinovirus-induced experimental asthma exacerbations

G. Rohde, S. D. Message, V. Laza-Stanca, P. Mallia, M. R. Edwards, S. L. Johnston (London, United Kingdom; Bochum, Germany)

Source: Annual Congress 2006 - Virus-induced respiratory tract infection
Session: Virus-induced respiratory tract infection
Session type: Oral Presentation
Number: 966
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Rohde, S. D. Message, V. Laza-Stanca, P. Mallia, M. R. Edwards, S. L. Johnston (London, United Kingdom; Bochum, Germany). Increase in α-defensins during rhinovirus-induced experimental asthma exacerbations. Eur Respir J 2006; 28: Suppl. 50, 966

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bacterial burden in rhinovirus-induced asthma exacerbations
Source: Lung Science Conference 2015
Year: 2015




An experimental model of rhinovirus-induced COPD exacerbation
Source: Annual Congress 2004 - Role of infection in COPD
Year: 2004


Role of respiratory infection in exacerbations of atopic asthma
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008

Effects of anti-IgE on asthma exacerbations
Source: Eur Respir J 2003; 22: Suppl. 45, 12s
Year: 2003

LSC Abstract – Bacterial burden in rhinovirus-induced asthma exacerbations
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015


Change in inflammation during COPD exacerbations
Source: Eur Respir J 2005; 26: Suppl. 49, 15s
Year: 2005

Could montelukast reduce asthma exacerbations?
Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008

Pollutant-induced acute exacerbations of asthma and COPD
Source: ERS Lung Science Conference 2019
Year: 2019


Antibiotics in acute exacerbation of asthma and COPD
Source: Eur Respir Monogr 2017; 75: 150-158
Year: 2017


Montelukast and frequency of exacerbations of asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 254s
Year: 2005

Acute exacerbations of asthma
Source: Eur Respir Monogr 2016; 74: 66-85
Year: 2016


Exacerbation of asthma
Source: Annual Congress 2008 - Exacerbations of chronic respiratory disease – state of the art
Year: 2008


Montelukast reduces viral-induced asthma exacerbations: the PREVIA study
Source: Eur Respir J 2004; 24: Suppl. 48, 212s
Year: 2004

The prevention of virus-induced exacerbation of bronchial asthma in children
Source: Annual Congress 2012 - Treating childhood asthma
Year: 2012



Antibiotics in exacerbations of asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline
Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges
Year: 2009

The effect of bronchiectasis on asthma exacerbations
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012